Diabetes News

Children who develop type 1 diabetes may have biomarkers present in the gut microbiome as early as age 1 year, according to a study published in Diabetologia.

Change in mean glucose may be a better metric for measuring the efficacy of diabetes interventions than HbA1c, time in range and time above range, according to a speaker.

About half of adults taking a novel peptide-based GLP-1/glucagon dual receptor agonist in development for the treatment of obesity in nonalcoholic steatohepatitis lost 10% or more body weight at 24 weeks, according to a press release.

Hepatic steatosis may be present in most adults with type 1 diabetes, especially those with overweight or obesity, according to a study published in Journal of Diabetes and Its Complications.

An increase in the incidence of gestational diabetes in Canada was primarily explained by changes in screening methods as opposed to changes in population factors, including older maternal age, according to researchers.

A colorectal cancer screening program in Denmark that used fecal immunochemical testing detected more cases among adults with diabetes and more cases at stage I of the disease than among those without diabetes, according to data published in Diabetic Medicine.

Compared with glucagon-like peptide-1 receptor agonists, patients with chronic kidney disease and type 2 diabetes experienced increased risks when taking SGLT2 inhibitors, according to published data.

The prevalence of diabetic retinopathy among children and adolescents with type 2 diabetes greatly increases 5 years after diabetes diagnosis, according to findings from a systematic review and meta-analysis.

MRI-determined placental volume, perfusion and visceral adiposity in early pregnancy were significantly associated with gestational diabetes, according to a prospective study published in The Journal of Clinical Endocrinology & Metabolism.

A high caffeine level in plasma was associated with reduced body fat and a lower risk for type 2 diabetes, according to a two-sample Mendelian randomization study published in BMJ Medicine.